The progression of carotid vascular remodeling risk factors in patients with arterial hypertension

The progression of carotid vascular remodeling risk factors in patients with arterial hypertension

Objective. To determine the clinical and genetic risk factors for the development and progression of carotid vascular remodeling according to the prospective observation after five years in patients with essential arterial hypertension (AH). Material and methods. The repeat clinical and instrumental...

Full description

Bibliographic Details
Main Authors:	O S Pavlova, I Yu Korobko, T A Nechesova, M M Liventseva, N V Zatoloka, E V Kovsh, S E Ogurtsova, A G Mrochek
Format:	Article
Language:	Russian
Published:	IP Morozov P.V. 2018-09-01
Series:	Системные гипертензии
Subjects:	essential arterial hypertension vascular remodeling carotid arteries intima-media complex genetic polymorphism renin-angiotensin-aldosterone system angiotensin ii type 1 receptor gene
Online Access:	https://syst-hypertension.ru/2075-082X/article/viewFile/29617/pdf

Similar Items

Effect of vitamin D intervention on the RAAS system activity and cardiovascular remodeling in spontaneously hypertensive rats
by: Hui Li1, et al.
Published: (2017-04-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
by: D. R. Kurbanova, et al.
Published: (2009-06-01)

Renin inhibitors are a new direction in the treatment of arterial hypertension
by: Yuriy Aleksandrovich Vasyuk, et al.
Published: (2010-09-01)

Genetic pathogenesis of essential arterial hypertension (the review)
by: Ruta A.V., et al.
Published: (2011-03-01)

Relationship between the expression of angiotensin II receptors type 1 and vasoactive regulators in arterial hypertension
by: Anna V. Logatkina, et al.
Published: (2020-11-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

Effect of renin-angiotensin -aldosterone system blockers on myocardial remodeling processes and risk for atrial fibrillation in patients with arterial hypertension
by: O. M. Drapkina, et al.
Published: (2014-07-01)

CLINICAL ASSOCIATIONS BETWEEN CORONAVIRUS INFECTION (COVID-19) AND ARTERIAL HYPERTENSION: PATHOGENETIC MECHANISMS AND DISCUSSION ON THE USE OF INHIBITORS OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
by: Yakubava L. V., et al.
Published: (2020-11-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

Direct renin inhibitor aliskiren in women with menopausal metabolic syndrome and arterial hypertension
by: Yu. V. Zhernakova, et al.
Published: (2011-08-01)

Neurohumoral regulation of blood pressure in rheumatic patients
by: N P Shilkina, et al.
Published: (2009-06-01)

The Relationship between Vitamin D Deficiency and Pulmonary Hypertension
by: Mehmet Demir, et al.
Published: (2013-01-01)

The role of the angiotensins in the pathogenesis of inflammatory joint disease
by: Andrei V. Gordeev, et al.
Published: (2021-05-01)

Analysis of renin-angiotensin-aldosterone system gene polymorphisms in resistant hypertension
by: S.R.S. Freitas, et al.
Published: (2007-03-01)

Role of atrial structural and functional changes in the development and progression of atrial fibrillation
by: O P Aparina, et al.
Published: (2014-01-01)

Evaluation of Systemic Renin and Angiotensin II Levels in Normal Tension Glaucoma
by: Soo Ji Jeon, et al.
Published: (2020-11-01)

Clinical perspectives and fundamental aspects of local cardiovascular and renal renin-angiotensin systems
by: Walmor eDe Mello, et al.
Published: (2014-02-01)

Dynamic changes of renin-angiotensin-aldosterone system parameters after surgery of primary hyperparathyroidism
by: E. A. Dobreva, et al.
Published: (2020-11-01)

Left ventricular hypertrophy and renin-angiotensin-aldosterone system: AT1-receptor blockers are in the focus
by: A V Barsukov, et al.
Published: (2013-03-01)

Effect of Ramipril on Renin-Angiotensin-Aldosterone System of Young and Middle-Aged Patients with Hypertension
by: Hui-Ling Yuan
Published: (2020-12-01)

Effects of Trandolapril on Structural, Contractile and Electrophysiological Remodeling in Experimental Volume Overload Heart Failure
by: Dagmar Jarkovská, et al.
Published: (2021-09-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
by: Ming-Hui Zheng, et al.
Published: (2020-08-01)

Prevalence of an angiotensin-converting enzyme gene variant in dogs
by: D. B. Adin, et al.
Published: (2021-07-01)

What is the optimal choice of antihypertensive therapy based on: the class-specific effects or special properties of a drug?
by: T V Adasheva, et al.
Published: (2013-09-01)

Myocardial functional status in patients with arterial hypertension and hyperaldosteronism: orthogonal electrocardiography assessment
by: Kh. F. Samedova, et al.
Published: (2006-04-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy
by: Zohreh Rahimi, et al.
Published: (2014-01-01)

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
by: Annina S. Vischer, et al.
Published: (2021-03-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

The Vasoactive Mas Receptor in Essential Hypertension
by: Amalie L. Povlsen, et al.
Published: (2020-01-01)

Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension
by: Natalia Muñoz-Durango, et al.
Published: (2016-06-01)

Neurohumoral activation in arterial hypertension pathogenesis among patients with hypoD and hyperthyrosis
by: P. Kh. Dzhanashiya, et al.
Published: (2005-10-01)

Dynamics of renin-angiotensin-aldosteron system and lipid profile in hypertensive hypothyrosis patients during the process of thyroid function compensation
by: P. Kh. Dzhanashiya, et al.
Published: (2004-12-01)

The Effect of Sodium Restricted Diet on Plasma Visfatin Levels in Hypertensive Patients with Visceral Obesity
by: Sylwia Rotkegel, et al.
Published: (2013-04-01)

Hyponatremic Hypertensive Syndrome in an Obese Man with Renal Ischemia
by: Saeed Khawer
Published: (2006-01-01)

Susceptibility to hypertensive renal injury mediated by P2X receptors
by: Menzies, Robert Ian
Published: (2014)

The role of tissue renin angiotensin aldosterone system in the development of endothelial dysfunction and arterial stiffness
by: Annayya R Aroor, et al.
Published: (2013-10-01)

INFLUENCE OF COMORBIDITIES ON BLOOD ALDOSTERONE LEVEL IN CHRONIC HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION OF THE LEFT VENTRICLE
by: N. T. Vatutin, et al.
Published: (2017-12-01)